Kristina E N Clark
University of Oxford · 81 works · 516 citations · h-index 15
Top works
- Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis
- A review of inflammatory idiopathic myopathy focusing on polymyositis
- Combining nano-physical and computational investigations to understand the nature of “aging” in dermal collagen
- Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis
- Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
- Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
- A critical analysis of the tools to evaluate neuropsychiatric lupus
- E050 Adverse infusion reactions to rituximab in myositis: a retrospective analysis
- Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019
- Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
- Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
- Intravenous immunogobulin therapy for severe gastrointestinal involvement in systemic sclerosis.
- Systemic sclerosis in pregnancy
- Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skin
- Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency
- Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
- The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
- Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis
- Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis
- Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients